No abstract available.
Nevus, Pigmented* ; Vitiligo*

The authors experienced a case of gastroduodenojejunal trichobezoar detected by ultrasongraphic examination. We thought that tricholbezoar had relatively specific ultrasonographic findings such as a broad hyperechogenic superficial bandlike rim with a complete posteior sonic shadowing and multiple linear echogenic strands on its surface representing hairs, which were better seen after water ingestion. So we were able to get the correct diagnosis of trichobezoar prior to conventional barium studies in a patient who could not be suspected suspected clinically.
Barium ; Bezoars* ; Diagnosis ; Eating ; Hair ; Humans ; Shadowing (Histology) ; Ultrasonography* ; Water

No abstract available.
Animals ; Interleukin-4* ; Mice*

No abstract available.
Spinal Cord Injuries* ; Spinal Cord*

No abstract available.
Adenoma* ; Ear*

PURPOSE: To evaluate the effects of oral Tamoxifen only versus L-Carnitine plus Tamoxifen in patients with Peyronie's disease. MATERIALS AND METHODS: All 45 patients with Peyronie's disease, diagnosed using accepted definitions, were randomized into two groups and treated for 3 months with Tamoxifen only(40 mg/day)(n=17) or a combination ofL-Carnitine(2 g/day) and Tamoxifen(40 mg/day)(n=28). A medical history was obtained, and a physical examination was performed. Plaque size, pain, erectile function(IIEF score), and penile curvature were assessed. Both before and after therapy, the differences between the 2 groups were compared using independent-sample t-test with p<0.05 considered significant. RESULTS: The mean age of the 45 patients was 52.1 years, and no severe adverse events occurred in either group. In the Tamoxifen only group, the mean decrease of plaque-length was 0.46+/-0.88 mm, and mean reduction in the pain rating scale was 0.44+/-0.53. In the L-Carnitine and Tamoxifen group, mean decrease of plaque-length was 1.57+/-0.92 mm, and mean reduction in the pain rating scale was 1.27+/-0.96. Based on IIEF scores, the improvement of erectile function was 0.88+/-0.64 in the Tamoxifen only group and 1.56+/-0.75 in the L-Carnitine and Tamoxifen group. The degree of penile curvature was also measured, and the reduction of curvature angle was 9.17+/-4.92 degrees in the Tamoxifen only group and 9.55+/-6.50 degrees in the L-Carnitine and Tamoxifen group. CONCLUSIONS: This study showed significantly greater improvements in plaque size, pain, erectile function, and curvature in patients with Peyronie's disease who were treated with L-Carnitine and Tamoxifen compared with those treated with Tamoxifen only.
Carnitine* ; Humans ; Male ; Penile Induration* ; Physical Examination ; Tamoxifen*

We report a case of woolly hair. Woolly hair is found frequently in most blacks but is unusual in individuals of non-negroid origin. A 12-year-old female patient visited our clinic complaining of a hair abnormality. It had been tightly curled, fine, light brown, short and easily broken since birth. On scanning electron microscopy, many of the hairs showed damaged cuticles with cuticular splintering, and most hair shafts were round to oval on cross sectional examination.
African Continental Ancestry Group ; Child ; Female ; Hair* ; Humans ; Microscopy, Electron, Scanning ; Parturition

No abstract available.

A medullary fibroma is the most common tumor found in the renal medulla and is seen incidentally in necropsy, but the usual small size and benignancy make clinical detection extremely rare. We report two cases of unusual renal medullary fibroma, incidentally discovered and accompanied by gross hematuria respectively in both sex. Radical nephrectomy and radical ureteronephrectomy with bladder cuff excision were performed because suspected to be malignant renal and renal pelvis tumor in X-ray and clinically. Histological examination revealed renal medullary fibroma. The diagnostic limitation and therapeutic dilemma associated with this condition are discussed.
Fibroma* ; Hematuria ; Kidney Pelvis ; Nephrectomy ; Urinary Bladder

PURPOSE: Status epilepticus (SE) is one of the most common neurologic emergencies in children requiring immediate aggressive intervention. Despite advances in treatment of this condition, SE is still associated with a significant morbidity and mortality. To evaluate etiology and neurologic outcome of SE is very important for improving the methods of evaluation and management of SE as well as decreasing morbidity and mortality. METHODS: We retrospectively reviewed the records of 98 children aged 1 month to 15 years who were admitted to our department of pediatrics from January, 1992 to December, 1998. We analyzed age distribution, etiology, seizure type, abnormalities of EEG and brain MRI, and neurologic outcome. We try to find any coherence between neurologic sequelae and clinical factors. RESULTS: The incidence was high in toddler age, especially younger than 3 years old (67.4%). Generalized convulsive SE was the most common type (67.3%), and 54.1% of children with SE which was the first seizure episode. Major etiology of SE in young children younger than 3 years old were febrile convulsion (54.5%) and acute symptomatic causes (22.7%). Neurologic sequelae were left in 21.4% and the mortality rate was 7.1%. The neurologic complications were highly associated with the underlying causes and the seizure durations, especially over 2 hour seizures left in 75% complications. The mortality and neurologic sequelae were higher in acute symptomatic SE than other causes. Febrile SE had usually benign course, but in four in our cases showed neurologic sequale it shows 4 neurologic sequelae cases. CONCLUSION: SE is a life-threatening neurologic condition and especially occurs in young children. The early detection of seizure etiology and aggressive management are the essential factors to decrease the mortality and morbidity rates.
Age Distribution ; Brain ; Child* ; Child, Preschool ; Electroencephalography ; Emergencies ; Humans ; Incidence ; Magnetic Resonance Imaging ; Mortality ; Pediatrics ; Retrospective Studies ; Seizures ; Seizures, Febrile ; Status Epilepticus*